topic

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma
Yuelong Wang, Jiaojiao Deng, Lin Wang, Tingyue Zhou, Jinlong Yang, Zerong Tian, Jinhao Yang, Hongxu Chen, Xin Tang, Shasha Zhao, Liangxue Zhou, Aiping Tong, Jianguo Xu

Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e000406; DOI: 10.1136/jitc-2019-000406
Malignant cell-specific CXCL14 promotes tumor lymphocyte infiltration in oral cavity squamous cell carcinoma
Anuraag Parikh, JuneHo Shin, William Faquin, Derrick T Lin, Itay Tirosh, John B Sunwoo, Sidharth V Puram

Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e001048; DOI: 10.1136/jitc-2020-001048
Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B
Ana Alvarez de Cienfuegos, Lawrence H Cheung, Khalid A Mohamedali, Timothy G Whitsett, Jeffrey A Winkles, Walter N Hittelman, Michael G Rosenblum

Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e001138; DOI: 10.1136/jitc-2020-001138
Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration
Hussein Sultan, Juan Wu, Valentyna I Fesenkova, Aaron E Fan, Diane Addis, Andres M Salazar, Esteban Celis

Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e001224; DOI: 10.1136/jitc-2020-001224
Avelumab for advanced Merkel cell carcinoma in the Netherlands: a real-world cohort
Sonja Levy, Maureen J B Aarts, Ferry A L M Eskens, Kristien B M I Keymeulen, Lukas B Been, Dirk Grünhagen, Alexander van Akkooi, Mathilde Jalving, Margot E T Tesselaar

Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e001076; DOI: 10.1136/jitc-2020-001076
Differential gene expression of tumor-infiltrating CD8⁺ T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis
Reem Saleh, Varun Sasidharan Nair, Salman M Toor, Rowaida Z Taha, Khaled Murshed, Mahmood Al-Dhaheri, Mahwish Khawar, Mahir Abdulla Petkar, Mohamed Abu Nada, Fares Al-Ejeh, Eyad Elkord

Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e001294; DOI: 10.1136/jitc-2020-001294
Targeted delivery of miR-99b reprograms tumor-associated macrophage phenotype leading to tumor regression
Liang Wang, Yi-Yang Hu, Jun-Long Zhao, Fei Huang, Shi-Qian Liang, Lei Dong, Yan Chen, Heng-Chao Yu, Jian Bai, Jia-Meng Yang, Jie-Yi Fan, Lei Feng, San-Zhong Li, Hua Han, Hong-Yan Qin

Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e000517; DOI: 10.1136/jitc-2019-000517
Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study
Kazuhiro Kakimi, Hirokazu Matsushita, Keita Masuzawa, Takahiro Karasaki, Yukari Kobayashi, Koji Nagaoka, Akihiro Hosoi, Shinnosuke Ikemura, Kentaro Kitano, Ichiro Kawada, Tadashi Manabe, Tomohiro Takehara, Toshiaki Ebisudani, Kazuhiro Nagayama, Yukio Nakamura, Ryuji Suzuki, Hiroyuki Yasuda, Masaaki Sato, Kenzo Soejima, Jun Nakajima

Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e001185; DOI: 10.1136/jitc-2020-001185
Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics
Katrin Rabold, Anna Aschenbrenner, Christoph Thiele, Collins K Boahen, Alexander Schiltmans, Johannes W A Smit, Joachim L Schultze, Mihai G Netea, Gosse J Adema, Romana T Netea-Maier

Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e000638; DOI: 10.1136/jitc-2020-000638
Leukemia escape in immune desert: intraocular relapse of pediatric pro-B-ALL during systemic control by CD19-CAR T cells
Semjon Willier, Johannes Raedler, Franziska Blaeschke, Dana Stenger, Montserrat Pazos Escudero, Florian Jurgeleit, Thomas G P Grünewald, Vera Binder, Irene Schmid, Michael H Albert, Armin Wolf, Tobias Feuchtinger

Journal for ImmunoTherapy of Cancer Sep 2020, 8 (2) e001052; DOI: 10.1136/jitc-2020-001052

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages